US · 1 sources covering this

Johnson & Johnson announces its entry into the US robotic surgery market

Johnson & Johnson secured FDA approval for its Ottava robotic surgical system. This authorization allows entry into the growing soft-tissue robotic surgery market. The system is approved for several general surgery procedures in the upper abdomen. Ottava features a smaller operating room footprint compared to existing systems. The company aims to challenge Intuitive Surgical's dominance in this field.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Times of IndiaLean R·3h ago
Johnson & Johnson announces its entry into the US robotic surgery market
Johnson & Johnson secured FDA approval for its Ottava robotic surgical system. This authorization allows entry into the growing soft-tissue robotic surgery market. The system is approved for several general surgery procedures in the upper abdomen. Ottava features a smaller operating room footprint compared to existing systems. The company aims to challenge Intuitive Surgical's dominance in this field.
Read at Times of India →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/d58e5bffd3ca17ee8fe179921bddf9e6939b195a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Johnson &amp; Johnson announces its entry into the US robotic surgery market"></iframe>

Johnson & Johnson announces its entry into the US robotic surgery market

How 1 sources are covering this